reference/34923996

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34923996

Outgoing Links

Predicate	Object
contentType	Randomized Controlled Trial\|Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1189
issn	0959-4973
issueIdentifier	10
pageRange	1183-1189
publicationName	Anti-Cancer Drugs
startingPage	1183
bibliographicCitation	Wang M, Ma Z, Li Q, Yang W, Chen X, Geng Y, Luo D, Hu Y, Wu B, Jiang W, Su S, Ouyang W, Lu B. Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer. Anticancer Drugs. 2023 Nov 01;34(10):1183–9. doi: 10.1097/cad.0000000000001501. PMID: 36727741.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c74e985c5c3f2f7dfd03a370a67ae99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_417ef7625924b7efe2a68aa36eaf1154 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3c7227f5147f7e6a24c79e2ce671927 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a6e6c626fa67ae128732839b7dcc44e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edba7b17e158bb1764e2ddbbbbaa1b16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2357d90d85cfc726833eec9fe3449d53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b71329a30c7c39eada80b3d66cbee80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89325f8c85b14147d4d7a48a76bca9c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8daca9e8f2963f10583579f9c9006f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80ac5de9953be89fe8cc2a8e32d6b465 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_307d74a66b7fed955c6a11d98acc8854 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f07da3bea75c0befe1a2f82a5d136b4
date	2023-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36727741 https://doi.org/10.1097/cad.0000000000001501
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1267 https://portal.issn.org/resource/ISSN/0959-4973
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer
discusses	http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0181802 http://id.nlm.nih.gov/mesh/M0007930
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D055752Q000188 http://id.nlm.nih.gov/mesh/D017564Q000188 http://id.nlm.nih.gov/mesh/D004941Q000188 http://id.nlm.nih.gov/mesh/D008175Q000532 http://id.nlm.nih.gov/mesh/D055752Q000532 http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002945 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D005047
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7811 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7655 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10051 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11136

Total number of triples: 53.